USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Paris Sciences ET Lettres - Quartier Latin

USPTO PatentsView assignee record - 20 granted patents across 34 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Paris ranks #14,846 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 34 technology areas.

#14,846
of 49,997 US assignees by volume
Top 33%
by Innovation Score (41.4/100)
15.4
avg claims per patent
+50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14846 · Foreign Corporation #14,846 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 20 grants
  • MID-PACK #14,846/49,997
  • PHOTO-FINISH Owl biomedical
  • CPC-FOCUS C12Q · 34 areas
  • INNOV-PAR 41.4/100
  • CLAIMS-RICH 15.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Owl biomedical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Paris

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Paris's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Paris's grants concentrate

Paris Sciences ET Lettres - Quartier Latin is a focused PatentsView assignee: 34 CPC subclasses with 25% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2021 (6 grants) versus a trough of 2 in 2017. By volume, Paris sits between Owl biomedical, Inc. and PHD, Inc..

Paris's three-year grant acceleration

Paris Sciences ET Lettres - Quartier Latin shows 2 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Paris's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Paris holds 20 patents at rank #14,840, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Paris

By rank, the assignees closest to #14,840 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Paris's primary technology class.

Paris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1234567 201720182019202020212024 2
USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Paris Sciences ET Lettres - Quartier Latin patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 10.0%
2018 3 15.0%
2019 3 15.0%
2020 4 20.0%
2021 6 30.0%
2024 2 10.0%

Which technologies does Paris Sciences ET Lettres - Quartier Latin patent most?

Top 15 of 34 technology areas

Where it ranks

Overall rank by patents

#14,846

of 49,997 tracked assignees

Innovation Score

41.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Paris Sciences ET Lettres - Quartier Latin's patent record in context - here's where to go next.

  • Paris Sciences ET Lettres - Quartier Latin's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 25% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #14,846 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Paris Sciences ET Lettres - Quartier Latin against Owl biomedical, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 41.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.